TAT-Gap19 H-IN-AZ1 InChi: InChI=1S/C35H56O8/c1-20(2)31(37)23(5)15-16-28(36)26(8)33(39)27(9)34-29(41-10)14-12-13-21(3)17-24(6)32(38)25(7)18-22(4)19-30(42-11)35(40)43-34/h12-16

InChi: InChI=1S/C35H56O8/c1-20(2)31(37)23(5)15-16-28(36)26(8)33(39)27(9)34-29(41-10)14-12-13-21(3)17-24(6)32(38)25(7)18-22(4)19-30(42-11)35(40)43-34/h12-16

once daily for 4 days) potently inhibits WiDr-induced angiogenesis

3-Dihydrobenzofuran) is an acetylcholinesterase (AChE) inhibitor isolated from leaves of L

CDDO-TFEA reduced immune and inflammatory cell populations

2-PMPA has neuroprotective activity in an animal model of stroke and anti-allodynic activity in CCI model

TAT-Gap19 H-IN-AZ1 InChi: InChI=1S/C35H56O8/c1-20(2)31(37)23(5)15-16-28(36)26(8)33(39)27(9)34-29(41-10)14-12-13-21(3)17-24(6)32(38)25(7)18-22(4)19-30(42-11)35(40)43-34/h12-16TAT Gap19, a Cx mimetic peptide, is a specific connexin43 hemichannel (Cx43 HC) inhibitor. TAT Gap19 does not inhibits the corresponding Cx43 GJCs. TAT Gap19 traverses the blood brain barrier and alleviate liver fibrosis in mice. Product information CAS Number: 1507930 54 2 Molecular Weight: 2703. 25 Formula: C119H212N46O26 Chemical Name: (2S) 6 amino 2 [(2S) 2 [(2S) 6 amino 2 [(2S) 6 amino 2 [(2S,3S) 2 [(2S) 2 [(2S,3S) 2 [(2S) 2 [(2S) 6 amino 2 [(2S)